Company intelligence / Profile preview

Ouroboros Neurotechnologies

Lausanne, Vaud, Switzerlandouroboros-neurotechnologies.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Neuropolis has demonstrated significant results in predicting fMRI data from EEG signals—a complex task that advances the field of neural interfaces. The company’s work suggests potential applications in improving non-invasive brain monitoring and foundational models for cognitive neuroscience research.

Therapeutic areas: Neurology
Modalities: Device (AI-powered neuroimaging software)Non-pharmacological therapy (biofeedback, neurofeedback, cognitive training platforms)
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on Ouroboros Neurotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ouroboros Neurotechnologies.

Explore the full profile